Drug formulations

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514284, 514357, A61K 3144, A61K 3154

Patent

active

061242829

ABSTRACT:
Various compounds that can inhibit the enzyme CYP2D6 are disclosed. The compounds are useful in increasing the effectiveness and reducing the abuse potential of drugs that are metabolised by CYP2D6.

REFERENCES:
patent: 5166207 (1992-11-01), Smith
patent: 5932589 (1999-08-01), Angeli
Derwent Abstract of WPIDS 66-27387F, 1993.
Benowitz NL, et al., Pharmacogenetics6,239-242, 1996.
Broly F, et al., DNA Cell Biol 1991:10, 545-558, 1991.
Busto, U.E., et al., Clin. Pharmacol. Ther. 55:451-463, 1994.
Caraco, Y., et al., J. Pharmacol. Exp. Ther. 281(1): 330-336, 1997.
Cone, E.J., et al., Drug Metab. Dispos. 6: 488-493, 1978.
Davis H, et al., Int J Addict 26, 777-795, 1991.
Dayer, P., et al., Biochem. Biophys. Res. Commun. 152:411-416, 1988.
Di Chiara, et al., Trends Pharmacol. Sci. 13: 185-193, 1992.
Fischman, M.W., et al., Br. J. Addict. 86: 1563-1570, 1991.
Heim, M.H., et al., Genomics 1002: 14, 49-58.
Herheimer A. Drug and Therapeutics Bulletin 23(16):62-64, 1985.
Holtzman S.G., J. Pharmacol. Exp. Ther. 214:614-9, 1980.
Isaac, P., et al., Can. J. Clin. Pharmacol. 2(2):81-86, 1995.
Jacqz-Agrain E., et al., Pharmacogenetics 3:197-204, 1993.
Jasinski, D.R.: Assessment of the abuse potential of morphine-like drugs (methods used in man). In Handbook of Experimental Pharmacology, vol. 45/I. Drug Addiction I: Morphine, Sedative Hypnotic and Alcohol Dependence. Ed. by: W.R. Martin, pp. 197-258, Springer-Verlag, Heidelberg, 1977.
Jensen, S. et al., Int. J. Leg. Med. 105:279-293, 1993.
Kaplan, H.L., et al., J. Pharmacol. Exp. Ther. in press.
Kathiramalainathan, K., Kaplan, H.L., Busto, U.E., Romach, M.K., Tyndale, R.F., Sellers, E.M. Abstracts of XIth International Symposium on Microsomes and Drug Oxidations (Los Angeles, California), 239, 1996.
Kauppila T., et al., Pharmacol. Biochem. Behav. 52:641-4, 1995.
Koyuncuoglu H., et al., Int. J. Clin. Pharmacol. Ther. Toxicol. 28:147-52, 1990.
Kroemer, H.K., et al., Life. Sci. 56(26): 2285-2298, 1995.
Mortimer, O., et al., Clin. Pharmaco.l Ther. 47: 27-35, 1990.
O'Brien, C.P. Drug addiction and drug abuse. In: Hardman J, Limbird L, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th edition. Toronto: MacGraw-Hill, 1996: 557-577.
O'Conner LE, et al., Inter J Addict 1995: 30, 541-555, 1995.
Otton SV, et al., Clin Pharmacol Ther 54, 463-472, 1993a, 53, 401-409, 1993b.
Pollack, B., Drug Info. J. 30:669-74, 1996.
Romach, M.K., et al., U.E., Am. J. Psychiatry, 1997 (submitted).
Shadel, M., et al., et al., J. Clin. Psycopharmacol 15(5):263-269, 1995.
Tyndale, R.F., et al., Pharmacogenetics 1997, 7:375-379, 1997.
Wu, D., et al., Br. J. Clin. Pharmac. 35: 30-34, 1993.
Wu D, Otton SV, Inaba T, Kalow W, Sellers EM. Interactions of amphetamine analogs with human liver CYP2D6. Biochem Pharmacol 1996 (in press).
Zawertailo, L.A., et al., J. Clin. Psychopharmacology 15(2): 117-124, 1995.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Drug formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug formulations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2100347

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.